Abiopharma

🔍 RYAN BERMAN BRIDGET (Director)

Company: NEWELL BRANDS INC. (NWL)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 30,418 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 68,144.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 40,200.00 | Footnotes: F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-05-07 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 135.00
• Sold 30,418 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-07 | Code: M | Exercise: 2026-05-07 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4
• Acquired 39,325 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 39,325.00 | transaction_form_type: 4 | Footnotes: F3, F5, F4

Footnotes:

• F1: Due to an administrative error, this figure had been previously understated by 18,285 shares, which were incorrectly incorporated into the separate line reporting the reporting person's Trust holdings. No transactions were omitted..
• F2: These shares were previously held directly, but were transferred to a trust for which the Reporting Person is Trustee.
• F3: Each restricted stock unit represents a contingent right to receive one share of Newell Brands Inc. common stock.
• F4: N/A
• F5: The award shall vest in full upon the earlier of: (i) the first anniversary of the date of the grant of the award or (ii) the next annual meeting of the Company's stockholders, which is at least 50 weeks after the immediately preceding year's annual meeting of the Company's stockholders; provided the Reporting Person remains in continuous service on the Board until such vesting date.